To determine if VGLL1 CTLs derived from patient MP015 could recognize allogeneic PDAC tumors, we tested a panel of HLA-A*0101-expressing PDAC tumor cell lines as targets for killing using a 51Cr release assay. This evidence concerns the gene VGLL1 and neoplasm.